NO174776C - Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI) - Google Patents

Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI)

Info

Publication number
NO174776C
NO174776C NO883271A NO883271A NO174776C NO 174776 C NO174776 C NO 174776C NO 883271 A NO883271 A NO 883271A NO 883271 A NO883271 A NO 883271A NO 174776 C NO174776 C NO 174776C
Authority
NO
Norway
Prior art keywords
tfi
tissue factor
factor inhibitor
isolating tissue
isolating
Prior art date
Application number
NO883271A
Other languages
English (en)
Norwegian (no)
Other versions
NO883271D0 (no
NO883271L (no
NO174776B (no
Inventor
George John Broze Jr
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22137642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO174776(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Washington filed Critical Univ Washington
Publication of NO883271D0 publication Critical patent/NO883271D0/no
Publication of NO883271L publication Critical patent/NO883271L/no
Publication of NO174776B publication Critical patent/NO174776B/no
Publication of NO174776C publication Critical patent/NO174776C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
NO883271A 1987-07-23 1988-07-22 Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI) NO174776C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7736687A 1987-07-23 1987-07-23

Publications (4)

Publication Number Publication Date
NO883271D0 NO883271D0 (no) 1988-07-22
NO883271L NO883271L (no) 1989-01-24
NO174776B NO174776B (no) 1994-03-28
NO174776C true NO174776C (no) 1994-07-06

Family

ID=22137642

Family Applications (1)

Application Number Title Priority Date Filing Date
NO883271A NO174776C (no) 1987-07-23 1988-07-22 Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI)

Country Status (14)

Country Link
US (3) US6534276B1 (da)
EP (1) EP0300988A3 (da)
JP (1) JP2781391B2 (da)
KR (1) KR900007261B1 (da)
AU (1) AU604138B2 (da)
BR (1) BR1100464A (da)
CA (1) CA1338122C (da)
DK (1) DK174522B1 (da)
FI (1) FI97298C (da)
IL (1) IL87172A (da)
NO (1) NO174776C (da)
NZ (1) NZ225534A (da)
PT (1) PT88075B (da)
ZA (2) ZA885371B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL87171A (en) * 1987-11-23 1995-08-31 Monsanto Co cDNA of human tissue factor inhibitor
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
CA2049873C (en) * 1990-08-27 2001-12-04 Tze-Chein Wun Anticoagulant combination of laci and sulfated polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
KR100443572B1 (ko) * 2002-05-29 2004-08-09 광양청매실농원영농조합법인 매실 농축액 제조방법
ES2348230T3 (es) * 2002-06-07 2010-12-01 Dyax Corp. Prevención y reducción de la isquemia.
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
PL1981519T3 (pl) 2005-12-29 2018-07-31 Dyax Corp. Hamowanie proteaz
WO2007092607A2 (en) * 2006-02-09 2007-08-16 Genetech, Inc. Treatment of hemorrhagic viral infections using a tissue factor inhibitor
US20090075887A1 (en) * 2007-08-21 2009-03-19 Genzyme Corporation Treatment with Kallikrein Inhibitors
EP3115469B1 (en) * 2007-11-19 2020-04-29 Celera Corporation Lung cancer markers and uses thereof
US8637454B2 (en) 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
SMT201800552T1 (it) 2010-01-06 2018-11-09 Dyax Corp Proteine che legano la callicreina plasmatica
KR102320178B1 (ko) 2011-01-06 2021-11-02 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
US10428158B2 (en) 2014-03-27 2019-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
EP3387018A1 (en) 2015-12-11 2018-10-17 Dyax Corp. Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP4090427A1 (en) 2020-01-13 2022-11-23 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE81149B1 (en) * 1987-02-12 2000-05-03 Genentech Inc Methods and deoxyribonucleic acid for the preparation of tissue factor protein
US5223427A (en) * 1987-03-31 1993-06-29 The Scripps Research Institute Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain
JPH02501263A (ja) * 1987-06-12 1990-05-10 マウント　サイナイ　スクール　オブ　メディシン　オブ　ザ　シティー　ユニバーシティー　オブ　ニューヨーク ヒトの組織因子のクローニングと形質発現
US4966852A (en) * 1987-07-23 1990-10-30 Monsanto Company DNA clone of human tissue factor inhibitor

Also Published As

Publication number Publication date
FI97298B (fi) 1996-08-15
PT88075B (pt) 1995-06-30
NO883271D0 (no) 1988-07-22
JP2781391B2 (ja) 1998-07-30
ZA885370B (en) 1989-10-25
KR900007261B1 (en) 1990-10-06
US6534276B1 (en) 2003-03-18
US20040265981A1 (en) 2004-12-30
DK413588D0 (da) 1988-07-22
US6806360B2 (en) 2004-10-19
FI883477A0 (fi) 1988-07-22
DK413588A (da) 1989-01-24
CA1338122C (en) 1996-03-05
KR890001581A (ko) 1989-03-27
PT88075A (pt) 1989-07-31
NO883271L (no) 1989-01-24
FI97298C (fi) 1996-11-25
EP0300988A3 (en) 1990-04-11
BR1100464A (pt) 2000-02-08
JPS6447799A (en) 1989-02-22
IL87172A0 (en) 1988-12-30
EP0300988A2 (en) 1989-01-25
FI883477L (fi) 1989-01-24
US20030166194A1 (en) 2003-09-04
US7060805B2 (en) 2006-06-13
NO174776B (no) 1994-03-28
IL87172A (en) 1994-12-29
AU1928688A (en) 1989-02-02
NZ225534A (en) 1991-02-26
DK174522B1 (da) 2003-05-12
AU604138B2 (en) 1990-12-06
ZA885371B (en) 1989-04-26

Similar Documents

Publication Publication Date Title
NO174776C (no) Fremgangsmåte for isolering av vevsfaktorinhibitor (TFI)
FI95712C (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
NO179531C (no) Fremgangsmåte for brönnbehandling
NO880162D0 (no) Fremgangsmaate ved fremstilling av nye peptidaseinhibitorer
NO953043D0 (no) Fremgangsmåte for syntetisere acetotriglyceridfett
FI925883A7 (fi) Menetelmä ei-syntaasin ja syklo-oksygenaasin kaksoisinhibiittorien valmistamiseksi
HU893412D0 (en) Inhibitors of interleucin-1
PT87642A (pt) Process for the preparation of dopamine-beta-hydroxylase inhibitors
PL278941A1 (en) Method of obtaining novel dithiane derivative
PL274750A1 (en) Method of obtaining novel heterocylic compounds
PL277488A1 (en) Method of obtaining n-phosphono-methyliminoacetic acid
PL272952A1 (en) Method of obtaining derivatives of 6-deoxyguanine
NO173145C (no) Fremgangsmaate for behandling av voerter
AU2473388A (en) Treatment of factor viii inhibitors
RO92640A2 (ro) Metoda pentru tratamentul keratitelor virotice
PL271848A1 (en) Method of obtaining novel derivatives of phenyl 3-phenylbutyrate
LV5007A3 (lv) Piroglutamilsaturosu substratu iegusanas metode
PL274782A1 (en) Method of obtaining derivatives of dicyanopyrazine
SE8604947D0 (sv) Forfarande for reducering av formfel hos rorformiga metalliska foremal
IL123071A0 (en) Method for playing sequences of chords
IE862859L (en) INHIBITORS OF DOPAMINE-ß-HYDROXYLASE
BG43621A1 (en) Method forpreparing of modified microproducts
SE8704247D0 (sv) Method of treatment
SU1572502A1 (ru) Cпocoб oпpeдeлehия coctoяhия tkaheй пapoдohta
IE871889L (en) Inhibitor of protein synthesis

Legal Events

Date Code Title Description
MK1K Patent expired